Madison Asset Management LLC Buys New Position in Agilent Technologies, Inc. $A

Madison Asset Management LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 631,763 shares of the medical research company’s stock, valued at approximately $83,917,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Brighton Jones LLC boosted its holdings in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after purchasing an additional 769 shares during the period. Geneos Wealth Management Inc. lifted its position in Agilent Technologies by 54.8% in the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after purchasing an additional 212 shares during the last quarter. Acadian Asset Management LLC lifted its position in Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after purchasing an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies during the second quarter valued at approximately $273,000.

Agilent Technologies Stock Performance

Shares of A stock opened at $155.40 on Thursday. The firm has a market capitalization of $43.89 billion, a price-to-earnings ratio of 31.20, a PEG ratio of 2.63 and a beta of 1.25. The stock has a fifty day moving average of $136.44 and a 200 day moving average of $125.84. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the firm earned $1.31 EPS. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Analyst Upgrades and Downgrades

A has been the topic of several recent analyst reports. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a report on Friday, June 26th. They issued an “outperform” rating and a $155.00 target price on the stock. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price target on the stock. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, May 28th. Finally, Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.